Targeted Delivery of Nucleic Acid Therapeutics: Emerging Carriers and Applications in Common Metabolic and Inflammatory Diseases
New nucleic acid platforms are expanding treatment possibilities for diabetes, inflammation, and rare metabolic disorders.
This comprehensive review covers nucleic acid therapeutic platforms from mRNA vaccines to CRISPR delivery, examining applications in diabetes, inflammation, and rare metabolic conditions. No new clinical trial data are presented; the review synthesizes 2020-2025 literature.
What the study was
- Study design
- Narrative review
- Population
- Metabolic and inflammatory disease populations (diabetes, inflammation, cancer)
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- International Journal of Nanomedicine
Why it surfaced
Broad nucleic acid therapeutics review — valuable landscape coverage but no new clinical evidence. Matches metabolic disease watchlist.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.